McGill Alert / Alerte de McGill

Updated: Mon, 07/15/2024 - 16:07

Gradual reopening continues on downtown campus. See Campus Public Safety website for details.

La réouverture graduelle du campus du centre-ville se poursuit. Complément d'information : Direction de la protection et de la prévention.

Clinician-Rated Dimensions of Psychosis Symptom Severity (CRDPSS)

Full name of scale

Clinician-Rated Dimensions of Psychosis Symptom Severity

Languages

English

Rater

Clinician-rated

Training

No information found

Utility

It is used for research and clinical purposes, and measurement-based care.

It was presented in the DSM-5 as a new scale to assess the dimensional aspects of psychosis in daily clinical practice.

It is an eight-item dimensional clinician-rated assessment of symptoms commonly observed in psychotic disorders used to monitor treatment progress, track changes in the individual’s symptom severity and enhance clinical decision-making.

Time to complete

No information found

Cost/license

Permission to use scale must be requested. https://websrvapps.psychiatry.org/requestform/default.aspx

Park, S.-C., Lee, K. U., & Choi, J. (2016). Factor structure of the clinician-rated dimensions of psychosis symptom severity in patients with schizophrenia. Psychiatry Investigation, 13(2), 253–254. Follow this link for the article.

Narrow, W. E., Clarke, D. E., Kuramoto, S. J., Kraemer, H. C., Kupfer, D. J., Greiner, L., & Regier, D. A. (2013). DSM-5 field trials in the United States and Canada, Part III: development and reliability testing of a cross-cutting symptom assessment for DSM-5. American Journal of Psychiatry, 170(1), 71–82. Follow this link for the article.

Back to top